Starpharma (SPL) reported that AstraZeneca has commenced a phase 1 clinical trial of AZD0466 (DEP Bcl2/xL conjugate) and the first patient has been successfully dosed. The development of AZD0466, is being progressed under a multi-product license whereby Starpharma is eligible to receive development, launch and sales milestones of up to US$124 million, plus tiered royalties on net sales. The first dose of AZD0466 administered in the phase 1 trial has triggered a milestone payment to Starpharma of US$3 million
http://crweworld.com/article/news-provided-by-business-wire/1363908/starpharma-commencement-of-phase-1-trial-for-azd0466-utilising-dep-delivery-technology
Starpharma (SPL) reported that AstraZeneca has commenced a phase...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
-0.005(4.17%) |
Mkt cap ! $47.38M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.8¢ | 11.5¢ | $13.46K | 116.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 374820 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 13759 | 3 |
View Market Depth
| Last trade - 16.10pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
11.5¢ |
Change
-0.005 ( 4.17 %) |
||||
| Open | High | Low | Volume | ||
| 11.5¢ | 12.0¢ | 11.5¢ | 399474 | ||
| Last updated 14.56pm 16/05/2024 ? | |||||
| SPL (ASX) Chart |